An estimated two billion persons are latently infected with Mycobacterium tuberculosis. The host factors that initiate and maintain this latent state and the mechanisms by which M. tuberculosis survives within latent lesions are compelling but unanswered questions. One such host factor may be nitric oxide (NO), a product of activated macrophages that exhibits antimycobacterial properties. Evidence for the possible significance of NO comes from murine models of tuberculosis showing progressive infection in animals unable to produce the inducible isoform of NO synthase and in animals treated with a NO synthase inhibitor. Here, we show that O2 and low, nontoxic concentrations of NO competitively modulate the expression of a 48-gene regulon, which is expressed in vivo and prepares bacilli for survival during long periods of in vitro dormancy. NO was found to reversibly inhibit aerobic respiration and growth. A heme-containing enzyme, possibly the terminal oxidase in the respiratory pathway, likely senses and integrates NO and O2 levels and signals the regulon. These data lead to a model postulating that, within granulomas, inhibition of respiration by NO production and O2 limitation constrains M. tuberculosis replication rates in persons with latent tuberculosis.
Skip Nav Destination
Article navigation
1 September 2003
Article|
September 02 2003
Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program
Martin I. Voskuil,
Martin I. Voskuil
1Department of Medicine and Department of Microbiology and Immunology, Division of Infectious Diseases and Geographic Medicine, Stanford Medical School, Stanford, CA 94305
2Department of Microbiology, University of Colorado Health Sciences Center, Denver, CO 80262
Search for other works by this author on:
Dirk Schnappinger,
Dirk Schnappinger
1Department of Medicine and Department of Microbiology and Immunology, Division of Infectious Diseases and Geographic Medicine, Stanford Medical School, Stanford, CA 94305
Search for other works by this author on:
Kevin C. Visconti,
Kevin C. Visconti
1Department of Medicine and Department of Microbiology and Immunology, Division of Infectious Diseases and Geographic Medicine, Stanford Medical School, Stanford, CA 94305
Search for other works by this author on:
Maria I. Harrell,
Maria I. Harrell
3Department of Pathobiology, University of Washington, Seattle, WA 98195
Search for other works by this author on:
Gregory M. Dolganov,
Gregory M. Dolganov
4Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143
Search for other works by this author on:
David R. Sherman,
David R. Sherman
3Department of Pathobiology, University of Washington, Seattle, WA 98195
Search for other works by this author on:
Gary K. Schoolnik
Gary K. Schoolnik
1Department of Medicine and Department of Microbiology and Immunology, Division of Infectious Diseases and Geographic Medicine, Stanford Medical School, Stanford, CA 94305
Search for other works by this author on:
Martin I. Voskuil
1Department of Medicine and Department of Microbiology and Immunology, Division of Infectious Diseases and Geographic Medicine, Stanford Medical School, Stanford, CA 94305
2Department of Microbiology, University of Colorado Health Sciences Center, Denver, CO 80262
Dirk Schnappinger
1Department of Medicine and Department of Microbiology and Immunology, Division of Infectious Diseases and Geographic Medicine, Stanford Medical School, Stanford, CA 94305
Kevin C. Visconti
1Department of Medicine and Department of Microbiology and Immunology, Division of Infectious Diseases and Geographic Medicine, Stanford Medical School, Stanford, CA 94305
Maria I. Harrell
3Department of Pathobiology, University of Washington, Seattle, WA 98195
Gregory M. Dolganov
4Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143
David R. Sherman
3Department of Pathobiology, University of Washington, Seattle, WA 98195
Gary K. Schoolnik
1Department of Medicine and Department of Microbiology and Immunology, Division of Infectious Diseases and Geographic Medicine, Stanford Medical School, Stanford, CA 94305
Address correspondence to Gary K. Schoolnik, Beckman Center, Rm. 241, Stanford Medical School, Stanford, CA 94305. Phone: (650) 723-8158; Fax: (650) 723-1399; email: [email protected]
Abbreviations used in this paper: CcO, cytochrome c oxidase; DETA/NO, diethylenetriamine/nitric oxide adduct; DosR, dormancy survival regulator; GSNO, nitrosoglutathione; NO, nitric oxide; qRT, quantitative real-time reverse transcriptase.
The online version of this article includes supplemental material.
Received:
February 06 2003
Revision Received:
August 01 2003
Accepted:
August 01 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 198 (5): 705–713.
Article history
Received:
February 06 2003
Revision Received:
August 01 2003
Accepted:
August 01 2003
Citation
Martin I. Voskuil, Dirk Schnappinger, Kevin C. Visconti, Maria I. Harrell, Gregory M. Dolganov, David R. Sherman, Gary K. Schoolnik; Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program . J Exp Med 1 September 2003; 198 (5): 705–713. doi: https://doi.org/10.1084/jem.20030205
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement